# Ambrx

**Source:** https://www.startuphub.ai/startups/ambrx
**Profile type:** Startup

> Clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) for cancer treatment.

## About

Ambrx is a clinical-stage biopharmaceutical company that utilizes a proprietary synthetic biology technology platform to design and develop next-generation antibody-drug conjugates (ADCs). Their technology allows for the incorporation of synthetic amino acids into proteins, enabling site-specific, homogenous, and stable conjugation. This platform aims to overcome limitations of traditional conjugation technologies and create precision biologics with optimized safety and efficacy for treating various cancer indications.

## Key facts

- **Slug:** ambrx
- **Website:** https://www.ambrx.com/
- **Location:** San Diego, United States
- **Founded:** 2003-01-01
- **Operating status:** Inactive
- **Total funding:** $462M
- **Sectors / tags:** Biotechnology, Drug Discovery, Oncology, Antibody-Drug Conjugates (ADCs), Precision Medicine, Synthetic Biology

## Frequently asked

### What does Ambrx do?

Ambrx is a clinical-stage biopharmaceutical company that utilizes a proprietary synthetic biology technology platform to design and develop next-generation antibody-drug conjugates (ADCs). Their technology allows for the incorporation of synthetic amino acids into proteins, enabling site-specific, homogenous, and stable conjugation. This platform aims to overcome limitations of traditional conjugation technologies and create precision biologics with optimized safety and efficacy for treating var…

### What is Ambrx's revenue?

StartupHub estimates Ambrx's annual revenue at $33.1M (range $10.4M to $106.4M, 34% confidence), based on comparable companies in the sector.

### What is Ambrx's valuation?

StartupHub estimates Ambrx's effective valuation at $1.6B (range $1.2B to $2.8B, 10% confidence), based on comparable companies in the sector.

### How much funding has Ambrx raised?

Ambrx has raised a total of $462M in funding. The most recent round on record is ATM.

### Where is Ambrx headquartered?

Ambrx is headquartered in San Diego, United States.

### When was Ambrx founded?

Ambrx was founded in 2003.

### What industry does Ambrx operate in?

Ambrx operates in Biotechnology, Drug Discovery, Oncology, Antibody-Drug Conjugates (ADCs), Precision Medicine, Synthetic Biology.

### What is Ambrx's current status?

Ambrx's current operating status is: Inactive.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Ambrx",
          "item": "https://www.startuphub.ai/startups/ambrx"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/ambrx#webpage",
      "url": "https://www.startuphub.ai/startups/ambrx",
      "name": "Ambrx - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of Ambrx. Ambrx is a startup founded in 2003, operating in Biotechnology and Drug Discovery. Clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) for cancer treatment. Headquartered in San Diego, United States.",
      "dateModified": "2026-05-14T10:03:48.859+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/ambrx#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/ambrx#organization",
      "name": "Ambrx",
      "url": "https://www.ambrx.com/",
      "description": "This is the official profile of Ambrx. Ambrx is a startup founded in 2003, operating in Biotechnology and Drug Discovery. Clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) for cancer treatment. Headquartered in San Diego, United States.",
      "sameAs": [
        "https://www.startuphub.ai/startups/ambrx"
      ],
      "foundingDate": "2003-01-01",
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "San Diego",
        "addressCountry": "US"
      },
      "knowsAbout": [
        "Biotechnology",
        "Drug Discovery",
        "Oncology",
        "Antibody-Drug Conjugates (ADCs)",
        "Precision Medicine",
        "Synthetic Biology"
      ]
    }
  ]
}
```